SMARCB1 and schwannomatosis: Such a high rate of LZTR1 mutation in SMARCB1 mutation-negative schwannomatosis patients was not, however, observed in subsequent studies (Hutter et al. 2014; Paganini et al. 2015b; Smith et al. 2015).